These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases. Tayebi M; Hawke S Immunol Lett; 2006 Jun; 105(2):123-6. PubMed ID: 16621033 [TBL] [Abstract][Full Text] [Related]
44. Prion protein interconversions and the transmissible spongiform encephalopathies. Horiuchi M; Caughey B Structure; 1999 Oct; 7(10):R231-40. PubMed ID: 10545332 [TBL] [Abstract][Full Text] [Related]
45. Understanding the nature of prion diseases using cell-free assays. Lawson VA Methods Mol Biol; 2008; 459():97-103. PubMed ID: 18576150 [TBL] [Abstract][Full Text] [Related]
46. Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein. Thackray AM; Madec JY; Wong E; Morgan-Warren R; Brown DR; Baron T; Bujdoso R Biochem J; 2003 Feb; 370(Pt 1):81-90. PubMed ID: 12429022 [TBL] [Abstract][Full Text] [Related]
48. Prion protein interconversions. Caughey B Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):197-200; discussion 200-2. PubMed ID: 11260800 [TBL] [Abstract][Full Text] [Related]
49. Transmissible spongiform encephalopathies and the 'rogue share-holder protein' hypothesis. Sastry PS Med Hypotheses; 2000 Feb; 54(2):186-8. PubMed ID: 10790749 [TBL] [Abstract][Full Text] [Related]
50. Amyloidoses of the nervous system in the transmissible dementias. Piccardo P Arch Med Res; 1992; 23(1):3-6. PubMed ID: 1364059 [TBL] [Abstract][Full Text] [Related]
51. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation. Bate C; Tayebi M; Williams A BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734 [TBL] [Abstract][Full Text] [Related]